Any new opp in Diabetes launch?

I presume we have some Co promo position... just say’n...

 

Pfizer may pick up ERTU SGLT2 in Spring, that's assuming that they digit heads in R&D actually get it by the FDA. 2nd detail for ELIQUIS team?

 

Nah doubt it. Late to market, why would we get involved?

 

3Q IR call mentioned diabetes approval expected in December by FDA. Not sure what this means for the field force, is this a positive glimmer of hope?

 

pfizer reps won't have this. only Merck

 

its mercks